Tackling Non-Communicable Diseases In Low- and Middle-Income Countries: Is the Evidence from High-Income Countries All We Need?

Shah Ebrahim and colleagues argue that more research on non-communicable diseases (NCDs) in both high-income countries and low- and middle-income countries can result in mutual benefits and will help better address the growing burden of NCDs.

[1]  Raghubar D. Sharma.  Sick Societies: Responding to the Global Challenge of Chronic Disease , 2014 .

[2]  Sick societies: responding to the global challenge of chronic disease , 2013 .

[3]  M. Engelgau,et al.  Convergence of non-communicable and infectious diseases in low- and middle-income countries. , 2013, International journal of epidemiology.

[4]  Bernadette A. Thomas,et al.  Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[5]  R. Sacco,et al.  Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). , 2012, European heart journal.

[6]  R. Sacco,et al.  Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). , 2012, Global Heart.

[7]  M. Mckee,et al.  Increase in state suicide rates in the USA during economic recession , 2012, The Lancet.

[8]  Richard D. Smith.  Why a Macroeconomic Perspective Is Critical to the Prevention of Noncommunicable Disease , 2012, Science.

[9]  Amitava Banerjee,et al.  Tracking global funding for the prevention and control of noncommunicable diseases. , 2012, Bulletin of the World Health Organization.

[10]  D. Stuckler,et al.  Big Food, Food Systems, and Global Health , 2012, PLoS medicine.

[11]  Peter Byass,et al.  The INDEPTH Network: filling vital gaps in global epidemiology , 2012, International journal of epidemiology.

[12]  S. Casswell.  Tackling NCDs: a different approach is needed , 2012, The Lancet.

[13]  C. Boelen,et al.  Tackling NCDs: a different approach is needed , 2012, The Lancet.

[14]  R. Dandona,et al.  The Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a cluster randomized trial. , 2012, Journal of the American College of Cardiology.

[15]  C. Katlama,et al.  Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment , 2012, AIDS.

[16]  D. Stuckler,et al.  Sick individuals, sick populations: The societal determinants of chronic diseases , 2012 .

[17]  P. Cullinan,et al.  The asbestos disease epidemic: here today, here tomorrow , 2011, Thorax.

[18]  S. Yusuf,et al.  Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey , 2011, The Lancet.

[19]  Ailsa Lyons,et al.  Alcohol imagery and branding, and age classification of films popular in the UK , 2011, International journal of epidemiology.

[20]  M. Mckee,et al.  Commentary: UN high level meeting on non-communicable diseases: an opportunity for whom? , 2011, BMJ : British Medical Journal.

[21]  Martin McKee,et al.  UN High-Level Meeting on Non-Communicable Diseases: addressing four questions , 2011, The Lancet.

[22]  R. Beaglehole,et al.  UN high-level meeting on non-communicable diseases: Addressing four questions (Lancet (2011) DOI: 10.1016/S0140-6736(11)60879-9) , 2011 .

[23]  M. Poo,et al.  Grand challenges in global mental health , 2011, Nature.

[24]  Gretchen A. Stevens,et al.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants , 2011, The Lancet.

[25]  N. Pearce.  Epidemiology in a changing world: variation, causation and ubiquitous risk factors. , 2011, International journal of epidemiology.

[26]  Gretchen A. Stevens,et al.  National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3·0 million participants , 2011, The Lancet.

[27]  Gretchen A. Stevens,et al.  National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants , 2011, The Lancet.

[28]  Gretchen A. Stevens,et al.  National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants , 2011, The Lancet.

[29]  Zaid Chalabi,et al.  Health, agricultural, and economic effects of adoption of healthy diet recommendations , 2010, The Lancet.

[30]  M. Flather.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010 .

[31]  C. Wen,et al.  The reduction of tuberculosis risks by smoking cessation , 2010, BMC infectious diseases.

[32]  N. Crisp.  Turning the World Upside Down: The search for global health in the 21st Century , 2010 .

[33]  A. Jemal,et al.  The global burden of cancer: priorities for prevention , 2009, Carcinogenesis.

[34]  A. Malarcher,et al.  Cigarette smoking among adults and trends in smoking cessation - United States, 2008. , 2009, MMWR. Morbidity and mortality weekly report.

[35]  Chris Trimble,et al.  How GE Is Disrupting Itself , 2009 .

[36]  Martin McKee,et al.  The public health effect of economic crises and alternative policy responses in Europe: an empirical analysis , 2009, The Lancet.

[37]  Jo Rycroft-Malone,et al.  An implementation research agenda , 2009, Implementation science : IS.

[38]  K. Brownell,et al.  The perils of ignoring history: Big Tobacco played dirty and millions died. How similar is Big Food? , 2009, The Milbank quarterly.

[39]  N. Drager,et al.  Trade and health: an agenda for action , 2009, The Lancet.

[40]  Vikram Patel,et al.  Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care , 2008, The Lancet.

[41]  C. Sabin,et al.  Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. , 2008, Circulation.

[42]  Shah Ebrahim,et al.  Prevention of chronic diseases: a call to action , 2007, The Lancet.

[43]  R. Horton,et al.  Scaling up interventions for chronic disease prevention: the evidence , 2007, The Lancet.

[44]  Stephen Colagiuri,et al.  Grand challenges in chronic non-communicable diseases , 2007, Nature.

[45]  C. Muntaner,et al.  Employment conditions and health inequalities. , 2007 .

[46]  M. Bates,et al.  Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. , 2007, Archives of internal medicine.

[47]  B. Bell,et al.  The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. , 2006, Journal of hepatology.

[48]  C. Murray,et al.  WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty , 2003, BMJ : British Medical Journal.

[49]  Raydel Valdés Salgado,et al.  [The Framework Convention on Tobacco Control]. , 2003, Salud publica de Mexico.

[50]  J. Douwes,et al.  Asthma and the westernization 'package'. , 2002, International journal of epidemiology.

[51]  Angus Deaton,et al.  Health, Inequality, and Economic Development , 2001 .

[52]  S. Ebrahim,et al.  Exporting failure? Coronary heart disease and stroke in developing countries. , 2001, International journal of epidemiology.

[53]  V. Moreno,et al.  Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective , 1995 .

[54]  N. Pearce.  Occupational cancer in developing countries , 1993, Cancer Causes & Control.

[55]  R Peto,et al.  Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. , 1991, BMJ.

[56]  G Rose,et al.  Sick individuals and sick populations. , 1985, International journal of epidemiology.

[57]  Maria Elisa Diazz.  World Health Organization , 1946, International Organization.

[58]  Diana Gosálvez Prados.  Global Burden of Disease Study 2010 , 2012 .

[59]  65th World Health Assembly closes with new global health measures. , 2012, Central European journal of public health.

[60]  W. J. Elliott,et al.  National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants , 2012 .

[61]  B. Gersh.  National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants , 2012 .

[62]  A. Feigl,et al.  The Global Economic Burden of Noncommunicable Diseases , 2012 .

[63]  K. Stronks,et al.  Non-communicable diseases , 2011 .

[64]  B. J. Gersh.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2011 .

[65]  J. Critchley,et al.  Sub Saharan Africa: TB and Diabetes Mellitus, HIV and Metabolic Syndrome, and the impact of globalization , 2009 .

[66]  R. Montezuma,et al.  Promoting active lifestyles and healthy urban spaces: the cultural and spatial transformation of Bogotá, Colombia. , 2005 .

[67]  N. Napalkov.  PREVENTION AND CONTROL OF NONCOMMUNICABLE DISEASES , 2000 .

[68]  Kenneth Jost.  Asthma Epidemic , 1999 .

[69]  T. Gross,et al.  For Personal Use. Only Reproduce with Permission from Elsevier Ltd Public Health Inequalities in Health between and within Countries: Poverty and Inequality Social Determinants of Health Inequalities , 2022 .